Clinical, electrocardiographic and echocardiographic abnormalities in Latin American migrants with newly diagnosed chagas disease 2005-2009, Barcelona, Spain

Eurosurveillance

Volumn 16, Issue 38, 2011, Pages

  Valerio, L ^a   Roure, S ^a   Sabria M ^b   Balanzo X ^c   Valles X ^b   Seres L ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL DE MATARÓ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHAGAS DISEASE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ETHNIC GROUP; FEMALE; HEART LEFT VENTRICLE RELAXATION; HEART LEFT VENTRICLE WALL MOTION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRATION; OBSERVATIONAL STUDY; SPAIN;

EID: 80053893549     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.16.38.19971-en     Document Type: Article

References (31)

1. Pan American Health Organization (PAHO). Enfermedad de Chagas (Tripanosomiasis americana). [Chagas disease (American tripanosomiasis)]. PAHO. [Accessed 2 Feb 2011]. Available from: http://www.paho.org/Project.asp?SEL=TP&LNG=SPA&CD=CHAGA&PRGRP=resourc_gen
2. Vasileva K. Statistics in focus. Citizens of European countries account for the majority of the foreign population in EU-27 in 2008. Luxembourg: Eurostat; 2009. Report No.: 94/2009. Available from: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-09-094/EN/KS-SF-09-094-EN.PDF
3. International Organization for Migration (IOM). IOM Migration Research Series No 16. Migration from Latin America to Europe: trends and policy challenges. IOM; May 2004. Available from: http://www.oas.org/atip/migration/iom%20report%20migration%20lac%20to%20eu.pdf
4. Biolo A, Ribeiro AL, Clausell AN. Chagas cardiomyopathy-where do we stand after a hundred years?. Prog Cardiovasc Dis. 2010;52(4); 300-316.
5. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115(1-2):22-27.
6. Rassi A Jr, Rassi A, Marin-Neto N. Chagas disease. Lancet. 2010;375(9723):1388-1402.
7. Kierszenbaum F. Mechanisms of pathogenesis in Chagas disease. Acta Parasitol. 2007;52(1):1-12.
8. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109-1123.
9. Punukollu G, Gowda RM, Khan IA, Navarro VS, Vasavada BC. Clinical aspects of the Chagas' heart disease. Int J Cardiol. 2007;115(3):279-283.
10. Spanish Government. Ministry of Immigration and Labour. La immigración en España: permanencia y equilibrio entre comunitarios y extracomunitarios. [Immigration in Spain: permanence and balance between EU and non-EU citizens].22 Aug 2011. Spanish. Available from: http://www.tt.mtin.es/periodico/inmigracion/201108/INM20110822.htm
11. Government of Catalonia. Department of Health. Protocolo de cribado y diagnóstico de la enfermedad de Chagas en mujeres latinoamericanas embarazadas y sus bebés. [Protocol for screening and diagnosis of Chagas disease in pregnant Latin American women and their babies]. Government of Catalonia.27 Jan 2010. Spanish. Available from: www.gencat.cat/salut/depsalut/html/es/dir125/chagasespanyol2010.pdf
12. Ministério da Saúde. Secretaria de Vigilância em Saúde. Consenso brasileiro em doença de chagas [Brazilian Consensus on Chagas Disease]. Rev Soc Bras Med Trop. 2005;38: Suppl 3: 7-29. Portuguese.
13. Mordini OD, Mitelman J. Clasificación Enfermedad de Chagas. Consenso Internacional Buenos Aires 2010. [Chagas disease classification. International Consensus Buenos Aires 2010]. [Accessed 5 May 2011]. Spanish. Available from: http://www.fac.org.ar/1/comites/chagas/Clasificacion_Enfermedad_de_Chagas.pdf
14. Hyland KV, Leon JS, Daniels MD, Giafis N, Woods LM, Bahk TJ, et al. Modulation of autoimmunity by treatment of an infectious disease. Infect Immun. 2007;75(7):3641-3650.
15. Silva-Grecco RL, Balarin MA, Correia D, Prata A, Rodrigues V Jr. Familial analysis of seroposivity to Trypanosoma cruzi and of clinical forms of Chagas disease. Am J Trop Med Hyg. 2010;82(1):45-48.
16. Black CL, Ocaña-Mayorga S, Riner DK, Costales JA, Lascano MS, Arcos-Terán L, et al. Seroprevalence of Trypanosoma cruzi in rural Ecuador and clustering of seropositity within households. Am J Trop Med Hyg. 2009;81(6):1035-1040.
17. Silva S, Gontijo ED, Amaral CF. Case-control study of factors associated with chronic Chagas heart disease in patients over 50 years of age. Mem Inst Oswaldo Cruz. 2007;102(7): 845-851.
18. Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzman S, Moreno Barral J, et al. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitemia detected by polymerase chain reaction. Heart. 2003:89(10):1186-1190.
19. Jackson Y, Getaz L, Wolff H, Holst M, Mauris A, Tardin A, et al. Prevalence, clinical staging and risk for bloodborne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis.2010;4(2):e592.
20. Lescure FX, Paris L. Elghouzzi MH, Le Loup G, Develoux M, Touafek F, et al. [Experience of targeted screening of Chagas disease in Ile-de-France]. Bull Soc Pathol Exot. French. 2009; 102: 295-299.
21. Muñoz J, Gomez i Prat J, Gállego M, Gimeno F, Treviño B, López- Chejade O, et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop. 2009;111(1): 51-55.
22. Moretti E, Castro I, Franceschi C, Basso B. Chagas disease: serological and electrocardiographic studies in Wichi and Creole communities of Misión Nueva Pompeya, Chaco, Argentina. Mem Inst Oswaldo Cruz. 2010;105(5):621-627.
23. Hidron AI, Gilman RH, Justiniano J, Blakstock AJ, LaFuente C, Selum W, et al. Chagas cardiomyopathy in the context of the chronic disease transition. PLoS Negl Trop Dis. 2010;4(5):e688.
24. Maguire HJ, Hoff R, Sherlock I, Guimarães AC, Sleigh AC, Ramos NB, et al. Cardiac morbidity and mortality due to Chaga's disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987;75(6):1140-1145.
25. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, et al. Long term cardiac outcomes of treating chronic Chagas disease with benznidazol versus not treatment: a nonrandomized trial. Ann Intern Med. 2006;144(10):724-734.
26. Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007;115:1124-1131.
27. Gurgel CB, Ferreira MC, Mendes CR, Coutinho E, Favoritto P, Carneiro F. [Apical lesions in Chaga's disease patients: an autopsy study]. Portuguese. Rev Soc Bras Med Trop. 2010;43(6):709-712.
28. Rigou DG, Gullone N, Carnevali L, De Rosa AF. Chagas asintomático. Hallazgos electrocardiograficos y ecocardiograficos. [Asymptomatic Chagas disease. Electro and echocardiographic findings]. Medicina (Buenos Aires). 2001;61(5):541-544. Spanish.
29. Combellas I, Puigbo JJ, Acquatella H, Tortoledo F, Gómez JR. Echocardiographic features of impaired left ventricular diastolic function in Chaga's disease. Br Heart J. 1985;53(3):298-309.
30. Patel AR, Lima C, Parro A, Arsenault M, Vannan MA, Pandian NG. Echocardiographic analysis of regional and global left ventricular shape in Chagas' cardiomyopathy. Am J Cardiol. 1998;82(2):197-202.
31. Viotti RJ, Vigliano C, Laucella S, Lococo B, Petti M, Bertocchi G, et al. Value of echocardiography for dignosis and prognosis of chronic Chagas disease without heart failure. Heart. 2004;90(6):655